SYMPAZAN Trademark

Trademark Overview

On Friday, June 16, 2017, a trademark application was filed for SYMPAZAN with the United States Patent and Trademark Office. The USPTO has given the SYMPAZAN trademark a serial number of 87492332. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, May 16, 2025. This trademark is owned by MonoSol Rx, LLC. The SYMPAZAN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of neurological and central nervous system related diseases and disorders; pharmaceutical preparations for the treatment of epilepsy; Pharmaceutical preparations for treatment of diseases and disorders of the central nervous system; pharmaceutical preparations for the treatment of epilepsy and seizure disorders; Pharmaceutical preparations, namely, anticonvulsants, antiseizure medications, and benzodiazepines
sympazan

General Information

Serial Number87492332
Word MarkSYMPAZAN
Filing DateFriday, June 16, 2017
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, May 16, 2025
Registration Number5704037
Registration DateTuesday, March 19, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 3, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of neurological and central nervous system related diseases and disorders; pharmaceutical preparations for the treatment of epilepsy; Pharmaceutical preparations for treatment of diseases and disorders of the central nervous system; pharmaceutical preparations for the treatment of epilepsy and seizure disorders; Pharmaceutical preparations, namely, anticonvulsants, antiseizure medications, and benzodiazepines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 22, 2017
Primary Code005
First Use Anywhere DateWednesday, November 28, 2018
First Use In Commerce DateWednesday, November 28, 2018

Trademark Owner History

Party NameAQUESTIVE THERAPEUTICS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWarren, NJ 07059
Party NameAQUESTIVE THERAPEUTICS, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressWARREN, NJ 07059
Party NameMonoSol Rx, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressWarren, NJ 07059
Party NameMonoSol Rx, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressWarren, NJ 07059

Trademark Events

Event DateEvent Description
Thursday, August 24, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 20, 2017NEW APPLICATION ENTERED
Thursday, June 22, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 22, 2017ASSIGNED TO EXAMINER
Wednesday, September 13, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 3, 2017PUBLISHED FOR OPPOSITION
Tuesday, October 3, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 28, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, January 31, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, April 30, 2018SOU TEAS EXTENSION RECEIVED
Monday, April 30, 2018SOU EXTENSION 1 FILED
Monday, April 30, 2018SOU EXTENSION 1 GRANTED
Monday, November 26, 2018SOU EXTENSION 2 GRANTED
Wednesday, May 2, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 26, 2018SOU TEAS EXTENSION RECEIVED
Monday, November 26, 2018SOU EXTENSION 2 FILED
Wednesday, November 28, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 14, 2018TEAS STATEMENT OF USE RECEIVED
Friday, December 14, 2018USE AMENDMENT FILED
Tuesday, January 15, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 15, 2019STATEMENT OF USE PROCESSING COMPLETE
Monday, February 11, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, February 12, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, March 19, 2019REGISTERED-PRINCIPAL REGISTER
Thursday, August 25, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 25, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 25, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, August 25, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 19, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, July 26, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, July 26, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 26, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, July 26, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, July 26, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, July 26, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, May 16, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, May 16, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, May 16, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Monday, January 27, 2025TEAS SECTION 8 & 15 RECEIVED

Related Keywords

sympazan preparations pharmaceutical treatment disorders system epilepsy diseases nervous central antiseizure